Completed from United Kingdom
I loved the practical focus of the advanced pharma health economics course. It helped me finally nail down the basics of budget impact modelling – something I’d struggled with before. The interactive webinars were relaxed yet packed with useful tips, and the downloadable Excel templates made it easy to apply what we learned straight away. I especially appreciated the real‑world examples from NHS drug appraisal committees. It’s a solid programme that’s given me confidence to take on more senior projects at work.
The Certificate in Pharmaceutical Health Economics (Advanced) perfectly aligned with my professional goals. The modules on cost‑effectiveness analysis gave me the tools to build a full economic model for a new oncology drug, which I later presented to my company's senior management. The case studies were directly relevant to real‑world pricing decisions, and the reading list featured up‑to‑date journal articles and industry reports. The instructor’s feedback on my assignments was prompt and insightful, helping me refine my analytical approach. Overall, the course exceeded my expectations and has already enhanced my credibility as a health economics analyst.
What an exhilarating experience! The course turned complex concepts like Markov modelling and willingness‑to‑pay thresholds into clear, actionable skills. I could immediately use the new techniques to evaluate a biosimilar launch strategy for my employer, which resulted in a 12% cost saving forecast. The video lectures were lively, and the discussion forum buzzed with peers from around the globe, adding diverse perspectives. The quality of the study materials—especially the step‑by‑step guides—was outstanding. I feel fully equipped to drive health‑economic decisions in my organization.
The advanced certificate offered a comprehensive deep‑dive into pharmaceutical health economics, which was exactly what I needed to bridge theory and practice. Detailed modules on sensitivity analysis and probabilistic modelling equipped me with the skills to construct robust economic evaluations for our local vaccine program. The course pack included high‑quality datasets and a well‑structured handbook that I could reference long after the sessions ended. The instructor’s thorough explanations and the opportunity to work on a capstone project using real South African market data made the learning experience both rigorous and relevant. I left the program confident in applying these methods to future health‑policy initiatives.
